Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection

Medicina y ciencias biológicas

• Coronavirus Infections 100%
• Drug Repositioning 95%
• Pharmaceutical Preparations 28%
• Coronavirus 25%
• tegobuvir 21%
• GS-5734 21%
• Drug Discovery 20%
• bictegravir 19%
• Drug Interactions 19%
• Drug Development 18%
• Respiratory System 18%
• favipiravir 17%
• prulifloxacin 17%
• carfilzomib 15%
• angiotensin converting enzyme 2 14%
• Nelfinavir 14%
• tocilizumab 14%
• Drug Receptors 13%
• Hydroxychloroquine 13%
• Pharmacology 13%
• Preclinical Drug Evaluations 11%
• Drug Design 11%
• Therapeutics 11%
• Chloroquine 11%
• Ribavirin 11%
• Pandemics 10%
• Viral Proteins 10%
• Toxicology 9%
• Glucocorticoids 9%
• Disease Outbreaks 8%
• Carrier Proteins 8%
• Pharmacokinetics 7%
• Costs and Cost Analysis 6%
• Lung 5%
• Infections 4%
• Proteins 3%

Química

• Drug 36%
• Favipiravir 7%
• Carfilzomib 6%
• Prulifloxacin 6%
• Hydroxychloroquine 6%
• Nelfinavir 5%
• Ribavirin 5%
• Chloroquine 4%
• Glucocorticoid 4%
• Angiotensin 4%
• Protein 4%
• Pharmacological Property 4%
• Molecule 3%
• Biological Property 3%
• Kd 2%
• Pharmacokinetics 2%
• Gibbs Free Energy 2%